Literature DB >> 6178872

Mechanisms of proteinuria in diabetic nephropathy: a study of glomerular barrier function.

B D Myers, J A Winetz, F Chui, A S Michaels.   

Abstract

The fractional clearance of neutral dextrans (theta D) with Einstein-Stokes radii between 30 and 64 A was determined in normal subjects (controls, N = 15) and in diabetic patients with heavy proteinuria (advanced nephropathy, N = 16) or trace proteinuria (early nephropathy, N = 8). When plotted on log normal probability coordinates, the correlation between theta D and radius in controls and in early diabetic nephropathy was linear, suggesting that glomerular pores form one population with a normal distribution. In advanced diabetic nephropathy, however, theta D for large molecules (radius greater than 46 A) was elevated and departed from linearity suggesting a bimodal pore size distribution within the glomerular membrane. A mathematical model was devised, which revealed the mean fraction of glomerular filtrate permeating the upper pore mode to be 0.009 +/- 0.002, and the pores to be totally nondiscriminatory toward molecules with radii up to 64 A. We conclude that the development of large pores (or defects) within the glomerular membrane in advanced diabetic nephropathy permits the unrestricted passage of large plasma proteins into the urine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6178872     DOI: 10.1038/ki.1982.71

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  Is the LPS-mediated proteinuria mouse model relevant to human kidney disease?

Authors:  Wayne D Comper
Journal:  Nat Med       Date:  2009-02       Impact factor: 53.440

2.  Nonenzymatic glycosylation-induced modifications of intact bovine kidney tubular basement membrane.

Authors:  S S Anderson; E C Tsilibary; A S Charonis
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

3.  Glomerular permselectivity factors are not responsible for the increase in fractional clearance of albumin in rat glomerulonephritis.

Authors:  K A Greive; D J Nikolic-Paterson; M A Guimarães; J Nikolovski; L M Pratt; W Mu; R C Atkins; W D Comper
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  Are the 'second generation' oral hypoglycemic agents really different?

Authors:  E F Pfeiffer
Journal:  Acta Diabetol Lat       Date:  1984 Jan-Mar

Review 5.  Where does albuminuria come from in diabetic kidney disease?

Authors:  Wayne D Comper; Leileata M Russo
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

6.  Evaluation of the presence of circulating immune complexes and their relationship to glomerular IgG deposits in streptozotocin-induced diabetic rats.

Authors:  C K Abrass
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

7.  Urinary protein excretion patterns in reactive (secondary) systemic amyloidosis.

Authors:  A M Teppo; C P Maury
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

Review 8.  The natural history of diabetic nephropathy in type I diabetes and the role of metabolic control in its prevention, reversibility and clinical course.

Authors:  B L Wajchenberg; E Sabbaga; J A Fonseca
Journal:  Acta Diabetol Lat       Date:  1983 Jan-Mar

9.  Variability of urine albumin excretion in normal and diabetic children.

Authors:  D M Gibb; V Shah; M Preece; T M Barratt
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

10.  A charge selectivity impairment in protein permselectivity is present in type 2 diabetes.

Authors:  S Morano; P Pietravalle; M G De Rossi; G Mariani; G Cristina; F Medici; M Sensi; D Andreani; U Di Mario
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.